Pharma By The Numbers: A Retrospective Look at the Industry and 20 Years of Xtalks History
XTalks
MARCH 22, 2023
Within 2009 and 2010, Swiss pharmas Roche and Novartis acquired Genentech and Alcon , respectively. However, Alcon has since separated from Novartis in 2019 and is now operating as a standalone eye care company. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more.
97 
Let's personalize your content